NYXH
NyxoahNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$128.27M
P/E Ratio
—
EPS
$-2.48
Beta
0.88
52W High
$8.59
52W Low
$2.72
50-Day MA
$3.08
200-Day MA
$4.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nyxoah
Nyxoah is an innovative medical technology company at the forefront of addressing obstructive sleep apnea (OSA) through its unique Genio system, which leverages minimally invasive hypoglossal nerve stimulation techniques. With a steadfast commitment to clinical validation, extensive research, and robust partnerships, Nyxoah is poised to enhance patient outcomes and improve the quality of life for millions affected by OSA. The company’s strategic focus on innovation within the sleep medicine sector positions it advantageously to meet the growing demand for effective treatment solutions, indicating strong potential for sustainable growth within the healthcare landscape.
Fundamentals
| Revenue (TTM) | $15.33M |
| Gross Profit (TTM) | $9.31M |
| EBITDA | $-82.04M |
| Operating Margin | -321.70% |
| Return on Equity | -130.00% |
| Return on Assets | -44.60% |
| Revenue/Share (TTM) | $0.39 |
| Book Value | $0.95 |
| Price-to-Book | 3.07 |
| Price-to-Sales (TTM) | 8.37 |
| EV/Revenue | 7.74 |
| EV/EBITDA | -2.00 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 498.90% |
| Shares Outstanding | $44.69M |
| Float | $24.49M |
| % Insiders | 36.18% |
| % Institutions | 21.36% |
Historical Volatility
HV 10-Day
66.48%
HV 20-Day
60.91%
HV 30-Day
61.89%
HV 60-Day
75.45%
HV Rank
56.7%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026